<DOC>
	<DOCNO>NCT00377273</DOCNO>
	<brief_summary>This study undertake : 1. ass safety fluorouracil cream treatment actinic keratoses ( `` AKs '' ) common skin surface area ( e.g. , posterior scalp , ear , neck , lip , arm hand ) ; 2. collect additional post-treatment safety data fluorouracil cream apply face ( include anterior scalp , applicable ) ; 3. ass incidence recurrence AKs face ; 4. ass need re-treatment fluorouracil cream face .</brief_summary>
	<brief_title>An Open-Label 18-Month Safety Study Fluorouracil Cream 0.5 % Treatment Actinic Keratoses</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . INCLUSION CRITERIA : Patients must give write informed consent ; Patients must least 5 visible and/or palpable AKs posterior scalp , ear , neck , lip , arm and/or hand ( across body site ) additional 5 visible and/or palpable AKs face ( include anterior scalp , applicable ) ; Female patient must postmenopausal least one year , hysterectomy , tubal ligation , use oral/systemic contraceptive , intrauterine device ( IUD ) Norplant start least 28 day prior study entry throughout study . Female patient childbearing potential must negative urine pregnancy test prior first application test medication Patients must compliant willing return study site designate followup visit . EXCLUSION CRITERIA : Pregnant lactating female ; Patients current skin condition face , scalp , ear , neck , lip , arm and/or hand could confound study , include basal cell squamous cell carcinoma ; Patients know allergy ingredient test drug formulation ; Patients know dihydropyrimidine dehydrogenase ( DPD ) enzyme deficiency ; Patients whose activity involve excessive prolonged exposure sunlight ; Patients use tan parlor ; Patients treat topical agent treatment actinic keratosis designate treatment area within 5 month prior start study prohibit ; Patients liquid nitrogen treatment AKs within 4 week prior study start designate treatment area ; History drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>